Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
Yahoo/Reuters
Mon, 05/19/25 - 10:33 pm
Pfizer
China
3SBio
cancer
oncology
non-small cell lung cancer
metastatic colorectal cancer
Saving pediatric cancer drugs from the ‘valley of death’
Beckers Hospital Review
Fri, 05/16/25 - 11:23 am
cancer
pediatric
oncology
drug development
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thu, 05/8/25 - 10:56 pm
FDA
Richard Pazdur
Marty Makary
cancer
oncology
JNJ
Pfizer
Roche
Urogen
J&J survey finds pace of oncology innovation is overwhelming physicians
Fierce Pharma
Thu, 05/8/25 - 11:17 am
JNJ
oncology
oncologists
physicians
innovation
AACR 2025: Quintet of investigational oncological drugs puts Ascentage on positive ascent
Pharmaphorum
Tue, 04/29/25 - 08:11 am
AACR
Ascentage Pharma
oncology
cancer
Mosaic adds to cancer combo pattern by licensing 2 clinical-stage drugs from Astex
Fierce Biotech
Thu, 04/24/25 - 10:50 am
Mosaic Therapeutics
Astex Pharmaceuticals
cancer
oncology
Boehringer to expand oncology presence with $572m Tessellate Bio deal
Pharmaceutical Technology
Wed, 04/23/25 - 09:42 am
Boehringer Ingelheim
Tessellate Bio
cancer
oncology
telomeres
NAYA Biosciences spins off cancer drug business 6 months after INVO merger
Fierce Biotech
Tue, 04/15/25 - 09:51 am
NAYA Biosciences
spinoffs
oncology
Fertility
From ADCs to radiopharma: How AstraZeneca is trying to ‘redefine oncology care’
Fierce Biotech
Wed, 04/9/25 - 10:59 pm
AstraZeneca
oncology
radiopharmaceuticals
AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama
Fierce Pharma
Mon, 03/17/25 - 10:11 pm
AstraZeneca
Alteogen
oncology
cancer
subcutaneous drug delivery
Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do
Pharma Voice
Mon, 03/17/25 - 10:13 am
radiopharmaceuticals
oncology
Ratio Therapeutics
Radiopharm Theranostics
Aktis Oncology
Perspective
‘I don't feel we lost momentum’: Takeda’s oncology execs sharpen focus after restructuring
Fierce Biotech
Thu, 03/13/25 - 11:21 pm
Takeda
oncology
R&D
restructuring
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena
Thu, 03/6/25 - 10:06 pm
Project Optimus
oncology
FDA
drug development
Its CEO died. The company scrapped a promising program. Now, for their 2nd act.
Pharma Voice
Thu, 02/27/25 - 10:12 am
Terns Pharmaceuticals
MASH
obesity
oncology
Pfizer taps a former Novartis exec to lead cancer drug push
BioPharma Dive
Thu, 02/6/25 - 11:38 am
Pfizer
Novartis
oncology
cancer
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Motley Fool
Sun, 01/26/25 - 04:13 pm
Eli Lilly
Verzenio
oncology
cancer
J&J oncology sales grow, but shares slide on outlook
BioPharma Dive
Wed, 01/22/25 - 12:01 pm
JNJ
earnings
oncology
Multiple Myeloma
Pfizer, under pressure to change, names oncology head as new R&D chief
BioPharma Dive
Wed, 11/20/24 - 11:33 am
Pfizer
R&D
oncology
Chris Boshoff
Pharma’s grip on cancer R&D is having unintended consequences
Pharma Voice
Wed, 11/13/24 - 10:52 am
R&D
cancer
oncology
After Pfizer deal, former Seagen CEO returns to lead oncology startup
BioPharma Dive
Mon, 10/28/24 - 11:10 am
David Epstein
Ottimo Pharma
Seagen
oncology
cancer immunotherapy
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »